| |
Latest 10 SEC filings (by transaction date) for CRBP within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 11/24 | Apr 10/24 | Moran Sean F. | Direct Ownership | Employee Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -1,787 | |
Apr 11/24 | Apr 10/24 | Moran Sean F. | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 1,787 | $30.00 |
Mar 11/24 | Mar 8/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 156,597 | $45.26 |
Mar 11/24 | Mar 8/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 61,668 | $44.62 |
Mar 11/24 | Mar 8/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 18,548 | $43.26 |
Mar 11/24 | Mar 8/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 24,983 | $42.25 |
Mar 11/24 | Mar 8/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 29,342 | $41.23 |
Mar 11/24 | Mar 8/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 8,862 | $45.96 |
Mar 11/24 | Mar 7/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 102,140 | $41.23 |
Mar 11/24 | Mar 7/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 90,325 | $39.99 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for CRBP within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 11/24 | Apr 10/24 | Moran Sean F. | Direct Ownership | Employee Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -1,787 | |
Apr 11/24 | Apr 10/24 | Moran Sean F. | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 1,787 | $30.00 |
Mar 11/24 | Mar 8/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 156,597 | $45.26 |
Mar 11/24 | Mar 8/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 61,668 | $44.62 |
Mar 11/24 | Mar 8/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 18,548 | $43.26 |
Mar 11/24 | Mar 8/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 24,983 | $42.25 |
Mar 11/24 | Mar 8/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 29,342 | $41.23 |
Mar 11/24 | Mar 7/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 102,140 | $41.23 |
Mar 11/24 | Mar 7/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 90,325 | $39.99 |
Mar 11/24 | Mar 7/24 | Cormorant Asset Management, LP | Indirect Ownership | Common Stock | P - Open market or private purchase | 10,736 | $39.13 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |